https://orcid.org/0000-0002-4885-4334
References
- Lorente L, Martín MM, Ortiz-López R, et al. Association between serum sFasL concentrations and sepsis mortality. Infect Dis. 2021;53(1):38–43.
- Boraschi D, Italiani P, Weil S, et al. The family of the interleukin-1 receptors. Immunol Rev. 2018;281(1):197–232.
- Biondo C, Mancuso G, Midiri A, et al. Essential role of interleukin-1 signaling in host defenses against group B streptococcus. mBio. 2014;5(5):e01428–01414.
- Almansa R, Heredia-Rodríguez M, Gomez-Sanchez E, et al. Transcriptomic correlates of organ failure extent in sepsis. J Infect. 2015;70(5):445–456.
- Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
- Guo L, Du Y, Qu S, et al. rVarBase: an updated database for regulatory features of human variants. Nucleic Acids Res. 2016;44(D1):D888–893.
- Schlüter T, Schelmbauer C, Karram K, et al. Regulation of IL-1 signaling by the decoy receptor IL-1R2. J Mol Med. 2018;96(10):983–992.
- Ahmad S, Singh P, Sharma A, et al. Transcriptome meta-analysis deciphers a dysregulation in immune response-associated gene signatures during sepsis. Genes. 2019;10(12):1005.
- Müller B, Peri G, Doni A, et al. High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration. J Leukoc Biol. 2002;72(4):643–649.
- Yimthin T, Cliff JM, Phunpang R, et al. Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis. Emerg Microbes Infect. 2021;10(1):8–18.